A carregar...
Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
BACKGROUND: Dyslipidemia and type 2 diabetes are two of the most significant risk factors for the development of cardiovascular disease. Measurement of lipoprotein subclasses provides important information about derangements in lipid metabolism and helps refine cardiovascular risk assessment. Exenat...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3500143/ https://ncbi.nlm.nih.gov/pubmed/23166441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S37969 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|